These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8657696)

  • 1. [Immunotropic activity of antimicrobial agents used in tuberculosis].
    Aleksandrova AE; Vinogradova TI
    Probl Tuberk; 1996; (2):43-5. PubMed ID: 8657696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cephalosporins as possible methods of etiotropic therapy of tuberculosis].
    Vinogradova TI; Aleksandrova AE; Tschegoleva RA
    Probl Tuberk; 1993; (4):45-8. PubMed ID: 8127841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of the activity of antitubercular agents with other antimicrobial agents].
    Vinogradova TI
    Probl Tuberk; 1994; (3):59-62. PubMed ID: 7937678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on the antituberculous activity of ofloxacins].
    Duan L; Liang G; Li H
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):98-100. PubMed ID: 10072834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy.
    Kalita A; Verma I; Khuller GK
    J Infect Dis; 2004 Oct; 190(8):1476-80. PubMed ID: 15378441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can ofloxacin constitute an alternative antitubercular treatment for BCG hepatitis?].
    Fendler JP; Debois H; Mége JL; Kepenekian G
    Prog Urol; 2002 Apr; 12(2):309-12. PubMed ID: 12108350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of individual drugs in the chemotherapy of tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
    JI B; Lounis N; Truffot-Pernot C; Grosset J
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1341-4. PubMed ID: 7574527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy of drug-resistant tuberculosis with inclusion of ofloxacin (zanocin)].
    Padeĭskaia EN
    Antibiot Khimioter; 2001; 46(8):9-18. PubMed ID: 11871320
    [No Abstract]   [Full Text] [Related]  

  • 14. Levofloxacin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):119-21. PubMed ID: 18486047
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
    Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
    Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila.
    Ko WC; Lee HC; Chuang YC; Ten SH; Su CY; Wu JJ
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1281-3. PubMed ID: 11257047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid.
    Tuberculosis (Edinb); 2008 Mar; 88(2):112-6. PubMed ID: 18486045
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance.
    Casal M; Ruiz P; Herreras A
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):588-91. PubMed ID: 10864193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
    Akaki T; Sato K; Shimizu T; Tomioka H; Kawahara S
    Kekkaku; 1997 Aug; 72(8):491-7. PubMed ID: 9293712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.